About Taiho Pharma Singapore

Company Philosophy


We strive to improve human health

and contribute to a society

enriched by smiles


Message from Managing Director

TAIHO PHARMA SINGAPORE PTE., LTD. ("Taiho Pharma Singapore") was established in Singapore in August 2011 as a wholly-owned subsidiary of Taiho Pharmaceutical Co., Ltd.

Sticking with our philosophy "by local. for local", Taiho Pharma Singapore covers a wide range of jobs such as clinical research, regulatory affairs, medical affairs and sales as a hub for Taiho’s oncology business in South East Asia in close touch with local medical oncologists and the other medical professionals in cancer care.

Taiho Pharma Singapore hopes to share our smile and happiness with local cancer patients, medical oncologists and the other medical professionals in cancer care in South East Asia by introducing our anticancer drugs and data with high quality.

Yoshimasa Nishimura

Company Overview

Establised August 8, 2011
Representative Yoshimasa Nishimura, Managing Director
Business Import/Export, Sales and Marketing of Pharmaceuticals,
Clinical Development
Head Office 390 Havelock Road #06-07, King's Centre
Singapore 169662
TEL: +65 6887 5104  FAX: +65 6887 3253

Parent Company

Establised June 1, 1963
Capital ¥ 200 million
Representative Masayuki Kobayashi, President and Representative Director 
No. of Employees 2,554 (as of December 31, 2014)
Sales ¥ 91,3 billion (fiscal 2014) *
Net Income ¥ 5,3 billion (fiscal 2014) *
Offices Head Office: Tokyo
Branches: 23 in Japan
Offices: 52 in Japan
Plants: 5 in Japan
Laboratories: Tokushima and Tsukuba (Ibaraki)
Head Office Location 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo, Japan ( MAP )
TEL: 81-3-3294-4527   

* Due to a change in the fiscal year end from March 31 to December 31, the fiscal year 2014 is the nine-month period from April through December.